Assertio Holdings (ASRT) Shares Outstanding (Weighted Average) (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Shares Outstanding (Weighted Average) came in at $6.4 million in Q1 2026, up 0.88% year-on-year from $6.4 million in Q1 2025, and little changed quarter-over-quarter from $6.4 million in Q4 2025.

Assertio Holdings (ASRT) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Shares Outstanding (Weighted Average) across 8 years of filings, most recently posting $6.4 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $6.4 million, up 0.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (up 0.88% YoY), and the FY2025 annual result was $6.4 million, up 0.82% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $6.4 million for Q1 2026 at Assertio Holdings, roughly flat from $6.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $96.0 million in Q3 2025 to a low of $6.4 million in Q4 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $51.0 million (2023), against an average of $55.6 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) jumped 86.22% in 2024 and tumbled 93.28% in 2025, its largest moves.
  • Assertio Holdings' Shares Outstanding (Weighted Average) stood at $47.0 million in 2022, then soared by 51.12% to $71.0 million in 2023, then sank by 91.06% to $6.4 million in 2024, then advanced by 0.82% to $6.4 million in 2025, then advanced by 0.48% to $6.4 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $6.4 million (Q1 2026), $6.4 million (Q4 2025), and $96.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 6.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.43 Mn
Dec 31, 2025 6.40 Mn
Sep 30, 2025 95.97 Mn
Jun 30, 2025 95.82 Mn
Mar 31, 2025 6.38 Mn
Dec 31, 2024 6.35 Mn
Sep 30, 2024 95.19 Mn
Jun 30, 2024 95.11 Mn
Mar 31, 2024 94.98 Mn
Dec 31, 2023 71.03 Mn
Sep 30, 2023 81.71 Mn
Jun 30, 2023 53.59 Mn
Mar 31, 2023 51.01 Mn
Dec 31, 2022 47.00 Mn
Sep 30, 2022 46.57 Mn
Jun 30, 2022 46.27 Mn
Mar 31, 2022 45.20 Mn
Dec 31, 2021 43.17 Mn
Sep 30, 2021 44.97 Mn
Jun 30, 2021 44.71 Mn